Below are the most recent publications written about "Markov Chains" by people in Profiles.
-
Bersani A, Amankwah M, Calvetti D, Somersalo E, Viceconti M, Davico G. Myobolica: A Stochastic Approach to Estimate Physiological Muscle Control Variability. IEEE Trans Neural Syst Rehabil Eng. 2024; 32:3270-3277.
-
Oliver BJ, Melmed GY, Siegel CA, Kennedy AM, Testaverde J, Oberai R, Alandra Weaver S, Almario C. A Hybrid Markov-SPC Approach to Assess Cost Differences in Urgent Care Utilization Using Patient-Reported Data in Inflammatory Bowel Disease. Perm J. 2024 09 16; 28(3):234-244.
-
Weintraub WS, Kolm P, Dolman S, Alva M, Bhatt DL, Zhang Z. Cost-Effectiveness of Sotagliflozin in SOLOIST-WHF. JACC Heart Fail. 2024 09; 12(9):1600-1610.
-
Torchia MT, Khan IA, Christensen DD, Moschetti WE, Fillingham YA. Universal Screening for Malnutrition Prior to Total Knee Arthroplasty Is Cost-Effective: A Markov Analysis. J Arthroplasty. 2023 03; 38(3):443-449.
-
Epstein D, Bootun R, Diop M, Ortega-Ortega M, Lane TRA, Davies AH. Cost-effectiveness analysis of current varicose veins treatments. J Vasc Surg Venous Lymphat Disord. 2022 03; 10(2):504-513.e7.
-
Anderson BR, Gotlieb EG, Hill K, McHugh KE, Scheurer MA, Mery CM, Pelletier GJ, Kaltman JR, White OJ, Trachtenberg FL, Hollenbeck-Pringle D, McCrindle BW, Sylvester DM, Eckhauser AW, Pasquali SK, Anderson JB, Schamberger MS, Shashidharan S, Jacobs JP, Jacobs ML, Boskovski M, Newburger JW, Nathan M. Registry-based trials: a potential model for cost savings? Cardiol Young. 2020 Jun; 30(6):807-817.
-
Wimo A, Handels R, Winblad B, Black CM, Johansson G, Salomonsson S, Eriksdotter M, Khandker RK. Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical Interventions. J Alzheimers Dis. 2020; 75(3):891-902.
-
Magnuson EA, Chinnakondepalli K, Vilain K, Kearon C, Julian JA, Kahn SR, Goldhaber SZ, Jaff MR, Kindzelski AL, Herman K, Brady PS, Sharma K, Black CM, Vedantham S, Cohen DJ. Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis: Results From the ATTRACT Trial. Circ Cardiovasc Qual Outcomes. 2019 10; 12(10):e005659.
-
Svedbom A, Dal?n J, Iverg?rd M, Borse RH, Black CM, Luttropp K, Kachroo S. The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitis. Eur J Health Econ. 2020 Feb; 21(1):45-54.
-
Choi H, Mohit B. Cost-effectiveness of screening for HLA-B*1502 prior to initiation of carbamazepine in epilepsy patients of Asian ancestry in the United States. Epilepsia. 2019 07; 60(7):1472-1481.